EUVIMEDEUVIMED entdecken
Multizentrische Studie

Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals

Peter J Kneuertz, Nestor Villamizar, Nasser K Altorki, Joseph D Phillips, Philipp Schnorr, Dan Jones, Shane Scott, Desmond M D'Souza, Ioana Baiu, Mahmoud Abdel-Rasoul, Joachim Schmidt, Dao M Nguyen und 1 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2025.07.030 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Peter J Kneuertz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, The Ohio State Wexner Medical Center, Columbus, Ohio. Electronic address: Peter.kneuertz@osumc.e…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Minimally Invasive Surgical Procedures, Pneumonectomy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We sought to analyze the outcomes of minimally invasive surgery and open resection of non-small cell lung cancer after neoadjuvant chemoimmunotherapy relative to treatment response. METHODS: Data from 5 centers in the United States and Germany were combined for all patients undergoing resection for non-small cell lung cancer after neoadjuvant chemoimmunotherapy between 2019 and 2024. Clinical and pathologic factors associated with minimally invasive surgery were analyzed. Minimally invasive surgery and open surgery outcomes were compared. RESULTS: A total of 207 patients were included, of whom 164 (79.2%) underwent minimally invasive surgery and 43 (20.8%) underwent open resection. Minimally invasive surgery was more commonly used for lobectomy (93.9% vs 58.8% open) and less frequently for bilobectomy (2.6% vs 14.7% open) or pneumonectomy (2.6% vs 26.5% open, P < .0001). Unplanned conversion to thoracotomy (9.1%, n = 15) occurred less often for robotic-assisted compared with video-assisted thoracoscopic surgery (4.5% vs 31%, P = .001). Open resection was used more often performed for larger residual tumors (ypT3/4, minimally invasive surgery 8.5% vs open 32.5%, P = .0002). A pathologic complete response in 39.1% of patients was an independent predictor of minimally invasive surgery (odds ratio, 10.81; 95% CI, 2.71-43.20; P = .001). Complete R0 resection was achieved in 96.1% of patients (minimally invasive surgery 98.2% vs open 88.4%, P = .003). Minimally invasive surgery was associated with shorter length of stay (adjusted median 3 days vs 7 days, P < .0001) and fewer major complications (9.1% vs 25.6%, P = .038). The 60-day mortality rate was 1%. CONCLUSIONS: Minimally invasive surgery is possible in most patients after neoadjuvant chemoimmunotherapy, especially after complete pathologic response, and is associated with high rates of complete resection and fast recovery. Open surgery is performed more often for patients with large residual tumors or those requiring extended resections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMinimally Invasive Surgical ProceduresPneumonectomyAgedFemaleHumansMaleMiddle AgedAcademic Medical CentersGermanyNeoadjuvant TherapyRetrospective StudiesRobotic Surgical ProceduresThoracic Surgery, Video-AssistedThoracotomyTreatment OutcomeUnited States

Stichwörter der Autor:innen

checkpoint inhibitorimmunotherapyminimally invasive surgeryneoadjuvantoutcomesroboticthoracoscopic

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Department of Surgery, The Ohio State Wexner Medical Center, Columbus, Ohio. Electronic address: Peter.kneuertz@osumc.edu.
  • Division of Cardiothoracic Surgery, The DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla.
  • Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
  • Department of Surgery, Section of Thoracic Surgery, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH.
  • Division of Thoracic Surgery, Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital Bonn, Bonn, Germany; Department of Thoracic Surgery, Helios Hospital Bonn/Rhein-Sieg, Bonn, Germany.
  • Division of Thoracic Surgery, Department of Surgery, The Ohio State Wexner Medical Center, Columbus, Ohio.

Zitieren

APA

Kneuertz, P. J., Villamizar, N., Altorki, N. K., Phillips, J. D., Schnorr, P., Jones, D., Scott, S., D'Souza, D. M., Baiu, I., Abdel-Rasoul, M., Schmidt, J., Nguyen, D. M., & Merritt, R. E. (2025). Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.07.030

Vancouver

Kneuertz PJ, Villamizar N, Altorki NK, Phillips JD, Schnorr P, Jones D, et al. Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2025.07.030

BibTeX
@article{Kneuertz2025,
  author = {Kneuertz, Peter J and Villamizar, Nestor and Altorki, Nasser K and Phillips, Joseph D and Schnorr, Philipp and Jones, Dan and Scott, Shane and D'Souza, Desmond M and Baiu, Ioana and Abdel-Rasoul, Mahmoud and Schmidt, Joachim and Nguyen, Dao M and Merritt, Robert E},
  title = {Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2025.07.030}
}
Kostenlos starten →